Clinical Trial Update: DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours [Phase 1]

View source ↗

Summary

A Phase 1 study of DT-9081 in adults with advanced, recurrent, or metastatic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• DT-9081

Snippet

Sponsor: Domain Therapeutics SA | Conditions: Solid Tumor, Adult | Phase 1 | Status: COMPLETED